Skip to content

ADMA Biologics ADMA Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$45.33M+68.5%$49.38M-55.9%$36.43M+1.4%$34.22M+6.7%$26.9M+51.1%
$1.8M-5.3%$2M0.0%$2M+5.3%$2M+5.3%$1.9M0.0%
$6.33M+36.9%$5.39M-0.8%$5.05M+58.8%$4.96M+73.3%$4.62M+116%
$58.25M+396%$35.64M-29.0%$13.29M-46.9%$21.14M-53.7%-$19.68M-787%
$2.54M-45.9%$1.08M-60.7%$14.37M+1,261%$2.42M+17.2%$4.7M+100%
$2.4M+151%-$276K+90.0%-$14.37M-1,209%-$2.53M-6.8%-$4.72M-99.8%
$130.19M$8.9M$0
-$10.13M-42.1%-$9.12M+70.6%-$27.83M-9.3%$0+100%-$7.13M-393%
$50.52M+260%-$28.9M-$31.52M-423%
$55.71M+329%$34.56M-27.2%-$1.08M-104%$18.72M-57.1%-$24.38M-434%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does ADMA Biologics generate?
ADMA Biologics (ADMA) generated $128.3M in operating cash flow over the trailing twelve months.
What is ADMA Biologics's free cash flow?
After $20.4M of capital expenditures, ADMA Biologics's free cash flow was $107.9M over the trailing twelve months, up 19.1% year over year.
Where does ADMA Biologics's cash flow data come from?
Every line is extracted from ADMA Biologics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.